BSX Q4 2018 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.6B+6.4% YoY

Gross Profit

$1.7B65.4% margin

Operating Income

$424M16.6% margin

Net Income

$386M15.1% margin

EPS (Diluted)

$0.27

QoQ Revenue Growth

+7.0%

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

-$87M

Stock-Based Comp.

$140M

Balance Sheet

Total Assets

$21.0B

Total Liabilities

$12.3B

Stockholders' Equity

$8.7B

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.6B	$2.4B	+6.4%
Gross Profit	$1.7B	$1.6B	+4.2%
Operating Income	$424M	$444M	-4.5%
Net Income	$386M	-$615M	+162.8%

Revenue Segments

Cardiovascular

$971M55%

MedSurg

$799M45%

Geographic Segments

UNITED STATES

$1.5B57%

Non-US

$1.1B43%